Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.31 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | DDO | Q99489 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7737173 | 0.79 | CA3 (0.39) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL13488 | 0.77 | CES2 (0.36) | CES2CES1 | |
| SCHEMBL155976 | 0.75 | CES2 (0.46) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL25346822 | 0.74 | CA3 (0.39) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL29987655 | 0.73 | PIM1 (0.41) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL1512796 | 0.73 | PIM1 (0.41) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL22861600 | 0.72 | KDM4E (0.40) | KDM4EDAODDO | |
| SCHEMBL8597374 | 0.72 | CES2 (0.44) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL29766667 | 0.72 | CA3 (0.42) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL669072 | 0.72 | CA3 (0.42) | CA3CA6CA5ACA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014152431-A1 | STABILIZATION OF RADIOIODINATED AND ASTATINATED PHARMACEUTIALS AND IMAGING AGENTS | Ground Fluor Pharmaceuticals, Inc. (US) | 2014-09-25 | — | — | WO | disclosed |
| US-20140275539-A1 | STABILIZATION OF RADIOIODINATED AND ASTATINATED PHARMACEUTICALS AND IMAGING AGENTS | Ground Fluor Pharmaceuticals, Inc. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140275539-A1 | STABILIZATION OF RADIOIODINATED AND ASTATINATED PHARMACEUTICALS AND IMAGING AGENTS | Ground Fluor Pharmaceuticals, Inc. (US) | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275539-A1 | STABILIZATION OF RADIOIODINATED AND ASTATINATED PHARMACEUTICALS AND IMAGING AGENTS | TTR, SSTR4, RNF114 | CA3 3550/4885CA6 3968/4885CA5A 4511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.